Citadel Advisors’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000
| Closed | -$30.5K | – | 14952 |
|
|
2025
Q1 | $30.5K | Sell |
1,000
-12,200
| -92% | -$411K | ﹤0.01% | 12803 |
|
|
2024
Q4 | $523K | Buy |
13,200
+4,600
| +53% | +$179K | ﹤0.01% | 8454 |
|
|
2024
Q3 | $334K | Buy |
8,600
+5,200
| +153% | +$210K | ﹤0.01% | 9105 |
|
|
2024
Q2 | $143K | Sell |
3,400
-1,300
| -28% | -$44.3K | ﹤0.01% | 10414 |
|
|
2024
Q1 | $138K | Buy |
4,700
+1,100
| +31% | +$35.1K | ﹤0.01% | 10893 |
|
|
2023
Q4 | $131K | Sell |
3,600
-100
| -3% | -$3.28K | ﹤0.01% | 10595 |
|
|
2023
Q3 | $119K | Sell |
3,700
-3,500
| -49% | -$119K | ﹤0.01% | 10671 |
|
|
2023
Q2 | $225K | Buy |
7,200
+3,000
| +71% | +$68.5K | ﹤0.01% | 9619 |
|
|
2023
Q1 | $95.7K | Sell |
4,200
-100
| -2% | -$2.58K | ﹤0.01% | 11330 |
|
|
2022
Q4 | $147K | Buy |
+4,300
| New | +$144K | ﹤0.01% | 10643 |
|
|
2022
Q2 | – | Sell |
-4,500
| Closed | -$204K | – | 14052 |
|
|
2022
Q1 | $204K | Buy |
+4,500
| New | +$197K | ﹤0.01% | 11495 |
|
|
2021
Q4 | – | Sell |
-6,100
| Closed | -$339K | – | 14712 |
|
|
2021
Q3 | $339K | Sell |
6,100
-5,400
| -47% | -$300K | ﹤0.01% | 10785 |
|
|
2021
Q2 | $624K | Sell |
11,500
-10,100
| -47% | -$554K | ﹤0.01% | 9524 |
|
|
2021
Q1 | $1.21M | Buy |
21,600
+13,200
| +157% | +$658K | ﹤0.01% | 7628 |
|
|
2020
Q4 | $366K | Buy |
+8,400
| New | +$331K | ﹤0.01% | 8727 |
|
|
2019
Q3 | – | Sell |
-8,900
| Closed | -$384K | – | 9721 |
|
|
2019
Q2 | $384K | Buy |
+8,900
| New | +$376K | ﹤0.01% | 7210 |
|
|
2018
Q4 | – | Sell |
-5,100
| Closed | -$381K | – | 9723 |
|
|
2018
Q3 | $381K | Buy |
+5,100
| New | +$351K | ﹤0.01% | 7166 |
|
|
2015
Q4 | – | Sell |
-7,700
| Closed | -$168K | – | 9174 |
|
|
2015
Q3 | $168K | Sell |
7,700
-700
| -8% | -$16.4K | ﹤0.01% | 6371 |
|
|
2015
Q2 | $197K | Buy |
8,400
+5,600
| +200% | +$140K | ﹤0.01% | 6345 |
|
|
2015
Q1 | $73K | Buy |
2,800
+2,700
| +2,700% | +$64.3K | ﹤0.01% | 7119 |
|
|
2014
Q4 | $2K | Sell |
100
-1,300
| -93% | -$27.5K | ﹤0.01% | 8375 |
|
|
2014
Q3 | $25K | Sell |
1,400
-800
| -36% | -$16K | ﹤0.01% | 7306 |
|
|
2014
Q2 | $47K | Sell |
2,200
-1,000
| -31% | -$21.4K | ﹤0.01% | 6785 |
|
|
2014
Q1 | $72K | Sell |
3,200
-1,100
| -26% | -$26.9K | ﹤0.01% | 6474 |
|
|
2013
Q4 | $105K | Sell |
4,300
-1,400
| -25% | -$33K | ﹤0.01% | 5567 |
|
|
2013
Q3 | $136K | Buy |
5,700
+2,900
| +104% | +$62.2K | ﹤0.01% | 5111 |
|
|
2013
Q2 | $56K | Buy |
+2,800
| New | +$70.1K | ﹤0.01% | 5605 |
|
Other funds holding SRDX
Citadel Advisors's SRDX Position: Q4 2025 in Review
Citadel Advisors sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 365,110 shares — an estimated $10.9M sold.
Citadel Advisors first reported a position in SRDX in Q2 2013 and held it in 42 quarters. The position peaked at $10.9M in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Citadel Advisors reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 365,110 Surmodics shares in Q4 2025, an estimated $10.9M.
- Citadel Advisors first reported a position in Surmodics in Q2 2013 and held it in 42 quarters.
- Citadel Advisors's Surmodics position peaked at $10.9M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.